DRUG · Mapped RxNorm record
suvorexant
Normalized identity: suvorexantView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
A Six Week, Randomized, Double-Blind Placebo-Controlled, Suvorexant Augmentation Study of Antidepressant Treatment of Major Depressive Disorder With Residual Insomnia
NCT02669030
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedA Six Week, Randomized, Double-Blind Placebo-Controlled, Suvorexant Augmentation Study of Antidepressant Treatment of Major Depressive Disorder With Residual Insomnia
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE4
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Depressionverified · MONDO: depressive disorder
MDDverified · MONDO: mal de Debarquement
Insomniaverified · MONDO: insomnia
Interventions
suvorexantDRUG · verified · RxNorm: suvorexant
PlaceboDRUG
Sponsors & collaborators
Augusta University, Dept. of Psychiatrycollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02669030 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.